Table 2.
Coefficient (βi) | SE | Odds Ratio | P-value | |
---|---|---|---|---|
Discharge Diagnosis: TIA mimics | ||||
Altered mental Status (0,1)a | 0.551 | 0.420 | 1.734 | 0.190 |
Hx of AF, PAF, A. Flutter (0,1) | −1.033 | 0.505 | 0.356 | 0.041 |
Hx of HTN (on Medication) (0,1) | 1.395 | 0.384 | 4.034 | 0.000 |
Hx of Hyperlipidemia (on Medication) (0,1) | 0.675 | 0.404 | 1.964 | 0.095 |
Hx of Seizure (0,1) | −1.657 | 0.811 | 0.191 | 0.041 |
Language disturbance-Expressive Aphasia (0,1) | −0.220 | 0.405 | 0.802 | 0.587 |
Numbness (Leg, Arm, or facial) (0,1) | 0.109 | 0.356 | 1.115 | 0.759 |
Pre-TIA OAC (0,1) - Coumadin, Pradaxa, Eliquis (apixaban), Xarelto | 0.618 | 0.629 | 1.855 | 0.326 |
Tobacco | 0.766 | 0.406 | 2.152 | 0.059 |
Weakness (general, unilateral arm or leg) (0,1) | −0.840 | 0.328 | 0.432 | 0.010 |
Hx of Carotid Disease | −0.202 | 0.608 | 0.817 | 0.740 |
Intercept | −0.637 | 0.562 | 0.529 | 0.257 |
Discharge Diagnosis: TIA | ||||
Altered mental Status (0,1)a | −1.494 | 0.698 | 0.225 | 0.032 |
Hx of AF, PAF, A. Flutter (0,1) | 0.036 | 0.575 | 1.037 | 0.950 |
Hx of HTN (on Medication) (0,1) | 1.509 | 0.540 | 4.522 | 0.005 |
Hx of Hyperlipidemia (on Medication) (0,1) | −0.726 | 0.483 | 0.484 | 0.133 |
Hx of Seizure (0,1) | −0.811 | 0.843 | 0.444 | 0.335 |
Language disturbance-Expressive Aphasia (0,1) | 0.330 | 0.503 | 1.391 | 0.511 |
Numbness (Leg, Arm, or facial) (0,1) | −0.784 | 0.442 | 0.456 | 0.076 |
Pre-TIA OAC (0,1) - Coumadin, Pradaxa, Eliquis (apixaban), Xarelto | −0.072 | 0.771 | 0.931 | 0.926 |
Tobacco | −0.498 | 0.588 | 0.608 | 0.397 |
Weakness (general, unilateral arm or leg) (0,1) | 0.443 | 0.442 | 1.557 | 0.316 |
Hx of Carotid Disease | 1.407 | 0.625 | 4.084 | 0.024 |
Intercept | −0.952 | 0.711 | 0.386 | 0.180 |
a Altered Mental Status was assessed based on level of consciousness (LOC), LOC Questions, and LOC Commands as defined in the National Institutes of Health Stroke Scale (NIHSS)